KVÅKVÅ3E0S30M — Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach
KVÅKVÅ3E00X0M — Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E0130M — Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
KVÅKVÅ3E0300M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach
KVÅKVÅ3E0330M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E0400M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
KVÅKVÅ3E0430M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
KVÅKVÅ3E0500M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
KVÅKVÅ3E0530M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
KVÅKVÅ3E0600M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach
KVÅKVÅ3E0630M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach
KVÅKVÅ3E0930M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
KVÅKVÅ3E0970M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening
KVÅKVÅ3E0A30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach
KVÅKVÅ3E0B70M — Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening
KVÅKVÅ3E0C70M — Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening
KVÅKVÅ3E0D30M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach
KVÅKVÅ3E0D70M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening
KVÅKVÅ3E0DX0M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach
KVÅKVÅ3E0E30M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach
KVÅKVÅ3E0E70M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening
KVÅKVÅ3E0E80M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0F30M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
KVÅKVÅ3E0F70M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0F80M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0G30M — Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach
KVÅKVÅ3E0G70M — Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening
KVÅKVÅ3E0G80M — Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0H30M — Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach
KVÅKVÅ3E0H70M — Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening
KVÅKVÅ3E0H80M — Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0J30M — Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
KVÅKVÅ3E0J70M — Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0J80M — Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0K30M — Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach
KVÅKVÅ3E0K70M — Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0K80M — Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0L30M — Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
KVÅKVÅ3E0L70M — Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
KVÅKVÅ3E0M30M — Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
KVÅKVÅ3E0M70M — Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening
KVÅKVÅ3E0N30M — Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach
KVÅKVÅ3E0N70M — Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening
KVÅKVÅ3E0N80M — Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0P30M — Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach
KVÅKVÅ3E0P70M — Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening
KVÅKVÅ3E0P80M — Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0Q00M — Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach
KVÅKVÅ3E0Q30M — Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach
KVÅKVÅ3E0Q70M — Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening
KVÅKVÅ3E0R30M — Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach
KVÅKVÅ3E0U30M — Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach
KVÅKVÅ3E0V30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach
KVÅKVÅ3E0W30M — Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach
